Embody ($199/mo month-to-month or $149/mo on a 12-month plan, flat)
In the SELECT trial , semaglutide 2.4 mg was associated with an average weight loss of nearly 10% over two years in adults with overweight or obesity who also had heart disease
Sometimes you realize you do better with a little help from the pros who help you stay motivated." "Chronos makes it easy, they give you the tools
Both are common among patients with diabetes and obesity, yet until recently, treatment options were mostly limited to lifestyle interventions or devices like continuous positive airway pressure (CPAP) machines
Our mission is to help you optimize your life from the inside out, providing you with fine-tuned, personalized programs that cater to your unique needs
Unlike low-touch programs, patients receive: Consistent communication with a licensed provider Flexible telehealth appointments Support for microdosing when appropriate Personalized treatment plans that evolve with progress Learn more about available programs here: GLP-1 Weight Loss Plans Why Provider-Led GLP-1 Care Matters GLP-1 medications like Semaglutide and Tirzepatide are powerful tools but results depend heavily on proper guidance
